Zobrazeno 1 - 10
of 19
pro vyhledávání: '"S. P. Harding"'
Autor:
P. Byrne, C. Thetford, M. Gabbay, P. Clarke, E. Doncaster, S. P. Harding, for the ISDR Study Group
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Internationally, systematic screening for sight-threatening diabetic retinopathy (STDR) usually includes annual recall. Researchers and policy-makers support extending screening intervals, citing evidence from observational studie
Externí odkaz:
https://doaj.org/article/ad237cc00bd84beaaec82d6e8936fe64
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Improving cardiac function through stem-cell regenerative therapy requires functional and structural integration of the transplanted cells with the host tissue. Visualizing the electromechanical interaction between native and graft cells nec
Externí odkaz:
https://doaj.org/article/f0c1c913e2c649e2b4f5c5f47804d119
Publikováno v:
Diabetic Medicine
Aim To summarize findings from studies reporting the prevalence and incidence of diabetic retinopathy and diabetic maculopathy in African countries in light of the rising prevalence of diabetes mellitus. Methods Using a predefined search strategy, we
Publikováno v:
Eye (London, England). 22(5)
To report overall patient recruitment characteristics and visual acuity (VA) outcome related to baseline lesion characteristics for patients with choroidal neovascularisation (CNV) treated with verteporfin photodynamic therapy (PDT) during its introd
Autor:
Andrew C, Browning, A K K, Chung, F, Ghanchi, S P, Harding, M, Musadiq, S J, Talks, Y C, Yang, W M, Amoaku
Publikováno v:
Ophthalmology. 112(7)
To report the 12-month results on the use of verteporfin photodynamic therapy (PDT) in the treatment of choroidal neovascularization (CNV) secondary to angioid streaks.Five-center prospective case series.Patients with CNV secondary to angioid streaks
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 20(9)
To measure the cumulative incidence of any retinopathy, maculopathy and sight-threatening diabetic retinopathy (STDR), and calculate optimal screening intervals by retinopathy grade at baseline for patients with Type 1 diabetes attending an establish
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 19
This article reviews the current status of retinopathy screening schemes in the UK. There is evidence that high-quality diabetic retinopathy screening schemes are in existence but provision is patchy. Many health authorities have ad hoc screening pro
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 13(10)
Blindness due to diabetes mellitus is potentially preventable in the majority of patient. Early detection of sight-threatening changes is associated with a better outcome, indicating the need to screen for retinopathy. At least 50% of diabetic patien
Publikováno v:
Orthopedics. 15(11)
Publikováno v:
BMJ. 312:440-441